StockData
Veradermics, Inc logo

Veradermics, Inc (MANE) stock

MANENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$124.86−0.78 (-0.62%)

Close on Nov 18, 2026Market cap $5.22BP/E –Yield –

Veradermics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Veradermics

Veradermics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Veradermics figures

See a number that looks wrong?